Faster Care for Low-Income Patients: New Lung Cancer Treatment Models Emerge

Andrew D. Smith
Published: Saturday, Jan 13, 2018
Brad Vincent, MD
Brad Vincent, MD
Improving outcomes for disadvantaged patients with lung cancer has been a priority for more than 5 years at Mary Bird Perkins—Our Lady of the Lake Cancer Center in Baton Rouge, Louisiana. The effort involves every aspect of lung cancer care, but the cancer center has worked hardest on the first step in the process: timely screening.

Far too many patients are diagnosed with incurable late-stage lung cancer. Nearly two-thirds of the 330 patients with lung cancer who came to Mary Bird Perkins in 2015 arrived with late-stage disease, and the proportion was even higher among patients on Medicaid—nearly 80% were first diagnosed with late-stage disease.

The organization’s leaders saw an opportunity to enhance outcomes by encouraging earlier screening. They developed a screening program with a satellite location in the neighboring city of Gonzales, and they peppered local primary care physicians (PCPs) with flyers to remind them of which patients should receive scans. More recently, the cancer center configured the electronic health records used by more than 100 affiliated PCPs so that they automatically suggest that screening referrals be written for qualifying patients.

“We know we have one of the largest at-risk populations in the country with regard to lung cancer, and our efforts have resulted in success in diagnosing early-stage lung cancers with a diagnostic yield similar to that seen in the landmark [National Cancer Institute] National Lung Screening Trial study,” said Brad Vincent, MD, chair of Mary Bird Perkins’ lung cancer multidisciplinary care team. “We have a long way to go to meet the needs of our community due to population growth, and are making strides every week to expand our reach, especially in the underserved areas. We recently partnered with Louisiana State University Health professionals who serve a large portion of that population. Hopefully, this partnership will translate into higher numbers screened and earlier diagnoses for our community.”

Efforts like that have not only begun to improve outcomes, they have also made Mary Bird Perkins 1 of 5 large practices chosen to help the Association of Community Cancer Centers devise an optimal care coordination model (OCCM) for patients with lung cancer on Medicaid. The final plan won’t be out for another year, but practices that want to improve their treatment of disadvantaged patients with lung cancer can get a head start by considering the most successful ideas from test sites such as Mary Bird or Genesis Cancer Care Center in Zanesville, Ohio.

High Tobacco Use Region

Most of Ohio is flat, fertile, and fully Midwestern, but the Buckeye State’s southeast corner is a tiny slice of Appalachia, a region where the largest industry is still coal mining, the unemployment rate tops 12%, and the antitobacco movement has mostly failed. Roughly 60% of all adults in the 6-county area smoke. Genesis’ modern facility—built 7 years ago to provide comprehensive cancer care in a region that had not been able to offer more than medical oncology—is designed to facilitate current standards of care. However, nurse navigators, financial counselors, and easy collaboration among different specialties cannot help patients who come in too late or fail to complete their treatment.

Before coming to Genesis, many patients with lung cancer endure 6 months of serious weight loss and breathlessness, wind up in the emergency department, and receive a diagnosis of incurable late-stage disease. This delay reflects both a general skepticism among the local population about the value of medical science and a general refusal among local PCPs to accept patients on Medicaid. Genesis hasn’t been able to make much of a dent in those problems, but it is working to slash by 50% or more the time between a patient’s first visit and first treatment.

“Patients used to come in once for imaging, make an appointment to get it read on another day, make an appointment to get a biopsy on a third day, make an appointment to get biopsy results on a fourth day, and so on,” said Scott A. Wegner, MD, the facility’s medical director. “A 60-day gap between first contact and first treatment was not unusual. We have already trimmed that considerably by combining steps, and we hope to get it well under a month by combining more.

“When we perform the initial scan here—a low-dose CT scan rather than the x-ray that many primary care physicians still use—we try to analyze it while the patient waits and perform any necessary biopsies that same day,” Wegner said. “When biopsies come back positive, we immediately assign each patient a navigator who specializes in lung cancer, and that navigator assembles a multidisciplinary team that devises a treatment plan, as opposed to automatically sending the patient first to a pulmonologist, then to a surgeon, then to oncologists.” The additional planning saves time in the long run.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x